Catalyst Wire Dossier Catalyst Wire Dossier

ASP2205

ASP2205 · Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP2205, covering 2016-06-21 to 2016-06-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of of ASP2205 [Phase 1]

See pricing